Navigation Links
ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2009 Financial Results
Date:10/2/2009

IRVINE, Calif., Oct. 2 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced it will release third quarter 2009 financial results after market close on November 3, 2009. In conjunction, the Company will host a conference call at 5:00 p.m. Eastern Time to discuss these results and provide a pipeline update.

Date: Tuesday, November 3, 2009

Time: 5:00 p.m. Eastern Time

Conference call access:

Internet: www.istavision.com

Domestic dial-in: 800-510-9691

International dial-in: 617-614-3453

Passcode: 62898415

To access the 24-hour audio replay, U.S. and Canadian participants may dial 888-286-8010; international participants may dial 617-801-6888. The access code for the replay is 52451599. This conference call also will be webcast live and archived on ISTA's website until December 3, 2009.

About ISTA Pharmaceuticals

ISTA Pharmaceuticals is the fourth largest branded ophthalmic pharmaceutical business in the U.S. ISTA's four marketed products plus its product candidates include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company is developing a strong product pipeline to fuel future growth and market share, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at http://www.istavision.com.

SOURCE ISTA Pharmaceuticals, Inc.


'/>"/>
SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. Alexza Pharmaceuticals to Present at the Fourth Annual JMP Securities Healthcare Focus Conference
2. Biostar Pharmaceuticals, Inc. Receives Patent for Aoxing Ganbao
3. Intercept Pharmaceuticals FXR Agonist INT-747 Meets Primary Endpoint in a Phase II Clinical Trial in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease
4. Merriman Curhan Ford Acted as Financial Advisor to TorreyPines Therapeutics, Inc. in the Completed Merger With Raptor Pharmaceuticals Corp.
5. Sanofi-aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM-121, an Anti-ErbB3 Monoclonal Antibody
6. Fovea Pharmaceuticals to be Acquired by sanofi-aventis
7. Sagent Pharmaceuticals Launches Vinorelbine Injection, USP
8. Cadence Pharmaceuticals to Webcast October 7th Analyst Day
9. Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
10. Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
11. Arena Pharmaceuticals to Host Conference Call and Webcast on Friday, September 18, 2009, to Discuss Results from the BLOSSOM Phase 3 Trial of Lorcaserin for Weight Management

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...rstCall/--EchoTherapeutics,Inc.(OTCBulletinBoard:E...CGMSystemasanon-invasive,wireless,transdermalconti...)SkinPrepSystemfortransdermaldrugdelivery,announce...cutiveOfficer,willpresentatthe13thAnnualBiotechand...ewYorkSocietyofSecuritiesAnalysts,at2:05onDecember...
(Date:11/24/2009)...Call/--ZimmerHoldings,Inc.(NYSE: ZMH ;SIX:ZMH)anno...rJaffrayHealthCareConferenceinNewYork,NewYork,onDe...castofthepresentationcanbeaccessedviaZimmer,sInves...Thewebcastwillbearchivedforreplayfollowingtheconfe...andheadquarteredinWarsaw,Indiana,Zimmerdesigns,dev...
(Date:11/24/2009)...l/--OptimerPharmaceuticals,Inc.(Nasdaq: OPTR )issc...areConferenceatTheNewYorkPalaceinNewYorkCityonDece...://www.newscom.com/cgi-bin/prnh/20090413/LA97352LO...beaccessibleontheInvestorspageoftheCompany,swebsit...tionwillbeavailableatthesamelocationfor30daysfollo...
Breaking Medicine Technology:Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2Cadient Group Brings Home the Gold and Two Bronze Aster Awards 12521 1Cadient Group Brings Home the Gold and Two Bronze Aster Awards 12521 2AccuVein Inks National Three Year Group Purchasing Deal With Amerinet 12519 1AccuVein Inks National Three Year Group Purchasing Deal With Amerinet 12519 2Oxygen Biotherapeutics Inc Announces Private Placement Financing Agreement and Offer to Acquire Warrants 48160 1Oxygen Biotherapeutics Inc Announces Private Placement Financing Agreement and Offer to Acquire Warrants 48160 2Oxygen Biotherapeutics Inc Announces Private Placement Financing Agreement and Offer to Acquire Warrants 48160 3
...irstCall/ --,SuperGen Inc. announced today that it...Association for Cancer Research,Annual Meeting on ...ll focus on data concerning many of SuperGen,s cur... kinase inhibitor compound,MP470 and its ability ...ancer cell drug resistance. Presentations will tak...
...lcerative Colitis, NEW YORK, April 05, 2007 /PRNew... , a developer of new drug treatments in the,fight...nounced,today additional data confirming efficacy ...eing developed for the treatment,of inflammatory b...al models of experimental colitis. Guanilib is an ...
Other Medicine Technology:SuperGen to Highlight Oncology Pipeline Data in Multiple,Presentations at AACR 2SuperGen to Highlight Oncology Pipeline Data in Multiple,Presentations at AACR 3SuperGen to Highlight Oncology Pipeline Data in Multiple,Presentations at AACR 4Callisto Intends to Move Guanilib into Clinical Trials in,Ulcerative Colitis 2Callisto Intends to Move Guanilib into Clinical Trials in,Ulcerative Colitis 3Callisto Intends to Move Guanilib into Clinical Trials in,Ulcerative Colitis 4
(Date:11/24/2009)...swire-USNewswire/--OnFriday,November20,juniorfeath...lblowtotheheadduringatitleboutinPhiladelphia.Hewas...hislifewereconducted,hewasdeclaredbraindeadonSunda...procurementorganization(OPO)servingeasternPennsylv...hehospitalaspartofstandardclinicalprocedurestodete...
(Date:11/24/2009)...RNewswire-USNewswire/--Parties,familydinners,andot...aycheer.Butthemerrimentcanchangetomiseryiffoodmake...om/cgi-bin/prnh/20090824/FDALOGO ) ,, Typicalsy...u-likesymptoms,whichcanstartanywherefromhourstoday...Thegoodnewsisthatpracticingfourbasicfoodsafetymeas...
(Date:11/24/2009)...RNewswire-USNewswire/--IPROhasachieveditsthirdcons...gementstandardfocusedonfulfillingcustomerrequireme...rovingbusinessperformance.CertificationtoISO9001:2...O,sQualityManagementSystem(QMS)haspassedarigorouse...keSuccessandAlbany,NewYorkaswellasatitsaffiliateLo...
(Date:11/24/2009)...RNewswire/--Mostpeoplelookforwardtokickingofftheho...ithfriendsandfamily.TheMacombCountyHealthDepartmen...idays.Travelingandbeinginlargegroupsareeasywaystos...hy: ,, VACCINATION ,, Thefirstandmostimpor...ccinatedagainsttheH1N1strainoftheflu.TheMacombCoun...
(Date:11/24/2009)...24/PRNewswire/--Nextmonth,UnitedHealthcarewilloffe...panic-AmericanseniorsunderstandthebasicsofMedicare...eeZumba®Goldclass,aLatin-infusedfitnessprogra...,andtango. ,, UnitedHealthcarewillofferthesesem...gedwhenlearningabouttheirhealthcareoptions. There...
Breaking Medicine News(10 mins):Health News:Paying Tribute to Boxer Francisco 'Paco' Rodriguez 2Health News:FDA Consumer Health Information: Food Safety Tips for Healthy Holidays 2Health News:IPRO Earns Third Consecutive Quality Management Certification 2Health News:Tips To Enjoy a Flu-Free Holiday Season 2Health News:UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program 2
...are ready to make major changes in their lives and...ations when faced with serious outbreak of pandemi...onducted by the Harvard School of Public Health (H...e for them if they become ill or would face seriou...
...ine used to treat cardiovascular diseases in China...onjunction// with traditional treatments, accordin...ies included in the review, taking tongxinluo impr...ac patients with angina. “Tongxinluo is one ...
...ished online this week in The Lancet warns that tu... a threat from tuberculosis strains //that are res... The study conducted by a team of researchers ... widespread in a rural area of KwaZulu Natal, Sout...
...diabetes in middle age could face more complicatio...ge, reveals a new study.// Elizabeth Selvin o...lth and other researchers looked at more than 2,80... The survey showed that more than 15 percent...
... shirk his responsibilities, Health Minister Anbum...the spread of dengue//, which has so far taken tol... interview with Karan Thapar for the CNN-IBN progr...nts who have to take steps." According to th...
... Eating Disorders, an international organization f...on professionals//, calls for a global ban on the ...s and in fashion magazines, and encourages the ind...recedented move of a major fashion show in Spain t...
Other Medicine News:Health News:Fears of Pandemic Flu makes Americans Ready for Change 2Health News:Fears of Pandemic Flu makes Americans Ready for Change 3Health News:Fears of Pandemic Flu makes Americans Ready for Change 4Health News:Fears of Pandemic Flu makes Americans Ready for Change 5Health News:Fears of Pandemic Flu makes Americans Ready for Change 6Health News:Some Evidence Shows Chinese Herbal Medicine Helps Angina Patients 2Health News:Some Evidence Shows Chinese Herbal Medicine Helps Angina Patients 3Health News:Threat posed by highly resistant strains of TB 2Health News:Ramadoss Blames State Governments for High Dengue Toll 2Health News:Ramadoss Blames State Governments for High Dengue Toll 3Health News:Academy for Eating Disorders Calls for Ban on Underweight Models 2
Burton SS760A A-Scan
Burton A-Scan/Pachymeter Combo
...CONMED's family of products allows you to tailor t... feature proprietary Energy Synchronous Processing...synchronization of current and voltage in all oper...e enables the system to sample current and voltage...
FLOSEAL
Medicine Products: